Skip to main content
ADTX
NASDAQ Life Sciences

Aditxt Seeks Shareholder Approval for Reverse Stock Split up to 1:250 to Maintain Nasdaq Listing

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$0.799
Mkt Cap
$411.385K
52W Low
$0.756
52W High
$5,214.678
Market data snapshot near publication time

Summary

Aditxt, Inc. has filed its definitive proxy statement for its annual meeting, seeking shareholder approval for a reverse stock split with a wide ratio range (1:2 to 1:250) to maintain its Nasdaq listing, alongside other routine proposals.


Key Events

  • Shareholder Meeting Scheduled

    The Annual Meeting of Stockholders is scheduled for May 1, 2026, where shareholders will vote on key proposals.

  • Reverse Stock Split Proposal

    Shareholders will vote on granting the board discretionary authority to effect a reverse stock split at a ratio between 1-for-2 and 1-for-250 within one year, primarily to maintain Nasdaq listing compliance.

  • Nasdaq Compliance Efforts

    This proposal addresses the minimum bid price requirement, following the company's recent regaining of compliance with Nasdaq's minimum stockholders' equity rule.

  • Executive Compensation and Related Party Loans

    The filing details executive salaries, notes that management voluntarily forgave salaried payroll in 2024 and 2025, and discloses significant loans from the CEO to the company in 2024 and 2025, which were subsequently paid off.


Analysis

This definitive proxy statement confirms Aditxt's intent to pursue a highly aggressive reverse stock split, a critical measure to address Nasdaq's minimum bid price requirement. This follows the recent 10-K filing which raised substantial doubt about the company's ability to continue as a going concern and highlighted significant delisting risk. While the company recently regained compliance with Nasdaq's minimum stockholders' equity rule, the proposed reverse split underscores ongoing challenges in maintaining its listing. The wide discretionary range for the split ratio (up to 1:250) suggests the board is preparing for a significant adjustment to the share price, which could be highly dilutive for existing shareholders if followed by further capital raises through its expanded At-The-Market (ATM) program. The disclosure of management voluntarily foregoing salary and the CEO providing substantial loans in prior years further illustrates the company's precarious financial position and management's efforts to sustain operations. Investors should monitor the outcome of the shareholder vote and the subsequent board decision on the reverse split ratio, as it will significantly impact the stock's trading dynamics and the company's ability to raise further capital.

At the time of this filing, ADTX was trading at $0.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $411.4K. The 52-week trading range was $0.76 to $5,214.68. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ADTX - Latest Insights

ADTX
Jun 11, 2026, 3:09 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.0124
Real-time Price: $0.0163 info
Change: +$0.0039 (+31%) info
Market Cap: $10.525K info
ADTX
Jun 10, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0189
Real-time Price: $0.0163 info
Change: -$0.0026 (-14%) info
Market Cap: $10.525K info
ADTX
Jun 10, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.029
Real-time Price: $0.0163 info
Change: -$0.0127 (-44%) info
Market Cap: $10.525K info
ADTX
Jun 09, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.033
Real-time Price: $0.0163 info
Change: -$0.0167 (-51%) info
Market Cap: $10.525K info
ADTX
Jun 09, 2026, 7:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
10
Price at Filing: $0.04803
Real-time Price: $0.0163 info
Change: -$0.03173 (-66%) info
Market Cap: $10.525K info
ADTX
Jun 05, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0597
Real-time Price: $0.0163 info
Change: -$0.0434 (-73%) info
Market Cap: $10.525K info
ADTX
Jun 01, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0999
Real-time Price: $0.0163 info
Change: -$0.0836 (-84%) info
Market Cap: $10.525K info
ADTX
May 29, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.142
Real-time Price: $0.0163 info
Change: -$0.1257 (-89%) info
Market Cap: $10.525K info
ADTX
May 22, 2026, 5:03 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.480
Real-time Price: $0.0163 info
Change: -$0.4637 (-97%) info
Market Cap: $10.525K info
ADTX
May 20, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.43
Real-time Price: $0.0163 info
Change: -$1.41 (-99%) info
Market Cap: $10.525K info